What is Lisa Alcamo Portale Rac email address?

Lisa Alcamo Portale Rac's primary email address is ********@poseida.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Lisa Alcamo Portale Rac work for?

Lisa Alcamo Portale Rac is a Senior Vice President Regulatory Affairs at Poseida Therapeutics, Inc., a company specializing in Commercial physical research.

Where Lisa Alcamo Portale Rac graduated from?

Lisa Alcamo Portale Rac holds a degree in Biology/Biological Sciences, General from Michigan State University.

How can I directly contact Lisa Alcamo Portale Rac?

To contact Lisa Alcamo Portale Rac directly, you can use the email address ********@poseida.com. Complete contact information is available upon registration with Muraena.

Who is Lisa Alcamo Portale Rac?

Lisa Alcamo Portale Rac is a distinguished Senior Vice President of Regulatory Affairs at Poseida Therapeutics, Inc., with a robust background in biotechnology and clinical development. With over two decades of experience, she has led regulatory strategies for major pharmaceutical companies, including Pfizer, where she was instrumental in the development of both biological and small molecule products across various therapeutic areas. Lisa's expertise spans global product lifecycle management, from early-phase clinical trials through to post-marketing, with a strong emphasis on oncology and immuno-oncology. She has a proven track record in navigating complex regulatory landscapes, successfully securing fast-track, orphan, and breakthrough designations for innovative therapies. Known for her leadership in team dynamics and mentoring, Lisa fosters a culture of growth and excellence within her teams. She holds a Bachelor of Science in Biology from Michigan State University and has worked with both Fortune 100 companies and startups, showcasing her versatility in diverse organizational environments. Her commitment to advancing regulatory affairs is matched by her passion for developing impactful therapies that improve patient outcomes.